Nail-Enthesis Connection PsA — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — A monoclonal TNF inhibitor with established efficacy across Crohn disease and recurrent uveitis
Explanation lettering: E = shown as A · C = shown as B · D = shown as C · B = shown as D · A = shown as E
A is correct. A monoclonal anti-TNF can address joints and skin, is preferred for recurrent uveitis and is an accepted IBD therapy. B lacks comparable efficacy for uveitis and Crohn disease. C risks exacerbating active IBD. D is not the preferred mechanism for substantial skin disease. E does not reliably control uveitis or moderate-to-severe Crohn disease.
Reference: EULAR recommendations for PsA pharmacological treatment 2023: https://ard.bmj.com/content/83/6/706